InsidersTradesSigma
신테카바이오 Stock: price and directors' dealings · South Korea · DART (FSS)
Track the 신테카바이오 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 신테카바이오 has logged 81 public disclosures. Market capitalisation: €39.3bn. The latest transaction was disclosed on 2 July 2026 (Other). Among the most active insiders: 정종선. The full history is free.
81
Insider Decl.
0
Thresholds
·
26 ops.
Buy Volume
·
4 ops.
Sell Volume
23Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 21,370 of 26,270 companies
29.7
score / 100
Value7
Quality52
FCF yld-26%
Earn yld-42%
EV/EBITDA·
ROE-59%
Gross mgn100%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 2 July 2026
Declarations81 total
25 of 81 declarations
About 신테카바이오
신테카바이오 is a company in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions for the medical field.